The FAVOR III trial (@favoriiitrial) 's Twitter Profile
The FAVOR III trial

@favoriiitrial

The FAVOR III Europe Japan Trial
QFR vs. FFR randomized non-inferiority trial
2000 patients in 35 European and Japanese heart centres

ID: 1161268058603831296

calendar_today13-08-2019 13:27:35

14 Tweet

156 Followers

60 Following

The FAVOR III trial (@favoriiitrial) 's Twitter Profile Photo

Great news from the The FAVOR III trial! Today, Dr. Liu and the team at Hagaziekenhuis in The Hague became the 7th site to begin enrolment in this exciting trial on #QFR vs FFR #QFRFirst

Great news from the <a href="/FAVORIIITrial/">The FAVOR III trial</a>! Today, Dr. Liu and the team at Hagaziekenhuis in The Hague became the 7th site to begin enrolment in this exciting trial on #QFR vs FFR #QFRFirst
The FAVOR III trial (@favoriiitrial) 's Twitter Profile Photo

A true landmark was reached in the The FAVOR III trial today! First Spanish patient enrolled by Dr. Hernán Mejía Rentería and the team at Hospital Clínico San Carlos, Madrid in a successful #QFR procedure. Congratulations! Javier Escaned Niels R. Holm Birgitte Krogsgaard Jelmer Westra Evald Høj Christiansen

A true landmark was reached in the <a href="/FAVORIIITrial/">The FAVOR III trial</a>
 today! First Spanish patient enrolled by Dr. Hernán Mejía Rentería and the team at Hospital Clínico San Carlos, Madrid in a successful #QFR procedure. Congratulations! <a href="/JEscaned/">Javier Escaned</a> <a href="/NielsRHolm/">Niels R. Holm</a> <a href="/B_Krogsgaard/">Birgitte Krogsgaard</a> <a href="/WestraJelmer/">Jelmer Westra</a> <a href="/h_evald/">Evald Høj Christiansen</a>
The FAVOR III trial (@favoriiitrial) 's Twitter Profile Photo

The second French center has now started active enrolment in the The FAVOR III trial! Congrats to Julienadjedj and his team at Institut Arnault Tzcank in Nice for enrolling their first two FAVOR III patients this week. Many thanks for your contribution on #QFR vs FFR!

The second French center has now started active enrolment in the <a href="/FAVORIIITrial/">The FAVOR III trial</a>! Congrats to <a href="/juliendjdj/">Julienadjedj</a> and his team at Institut Arnault Tzcank in Nice for enrolling their first two FAVOR III patients this week. Many thanks for your contribution on #QFR vs FFR!
The FAVOR III trial (@favoriiitrial) 's Twitter Profile Photo

Great news in the The FAVOR III trial! Yesterday, Dr. Thue Olsen and the FAVOR III team randomized their first patient at Gentofte Hospital, Denmark. Congratulations! #QFR #coronaryphysiology #cardiotwitter Thue Olsen Niels R. Holm Evald Høj Christiansen

Great news in the <a href="/FAVORIIITrial/">The FAVOR III trial</a>! Yesterday, Dr. Thue Olsen and the FAVOR III team randomized their first patient at Gentofte Hospital, Denmark. Congratulations! #QFR #coronaryphysiology #cardiotwitter <a href="/ThueOlsen/">Thue Olsen</a> <a href="/NielsRHolm/">Niels R. Holm</a> <a href="/h_evald/">Evald Høj Christiansen</a>
The FAVOR III trial (@favoriiitrial) 's Twitter Profile Photo

It is a great week in the The FAVOR III trial. Yet another center starting active enrolment! Many thanks to Dr. Karsten Lenk and his team at University Clinic Leipzig for their engagement in this important trial on #QFR vs. FFR. Niels R. Holm Evald Høj Christiansen Ashkan Eftekhari Birgitte Krogsgaard

It is a great week in the <a href="/FAVORIIITrial/">The FAVOR III trial</a>. Yet another center starting active enrolment! Many thanks to Dr. Karsten Lenk and his team at University Clinic Leipzig for their engagement in this important trial on #QFR vs. FFR. 
<a href="/NielsRHolm/">Niels R. Holm</a> <a href="/h_evald/">Evald Høj Christiansen</a> <a href="/AshkanEftekhar1/">Ashkan Eftekhari</a> <a href="/B_Krogsgaard/">Birgitte Krogsgaard</a>
The FAVOR III trial (@favoriiitrial) 's Twitter Profile Photo

The FAVOR III trial News! Two great Italian centers just enrolled their first patient. Congratulations to the teams at University Napoli Federico II and Arcispedale S. Maria Nuova di Reggio Emilia. Good job! Luigi Di Serafino @Iginio51341807 Giovanni Esposito #QFR

<a href="/FAVORIIITrial/">The FAVOR III trial</a> News! Two great Italian centers just enrolled their first patient. Congratulations to the teams at University Napoli Federico II and Arcispedale S. Maria Nuova di Reggio Emilia. Good job!
<a href="/llddss80/">Luigi Di Serafino</a> @Iginio51341807 <a href="/espogiov/">Giovanni Esposito</a> #QFR
The FAVOR III trial (@favoriiitrial) 's Twitter Profile Photo

First enrolment at Charite - Universitätsmedizin this morning! Congratulations to Prof. Dr. med. Ulf Landmesser and his team. This is great news for the The FAVOR III trial!

First enrolment at Charite - Universitätsmedizin this morning! Congratulations to Prof. Dr. med. Ulf Landmesser and his team. This is great news for the <a href="/FAVORIIITrial/">The FAVOR III trial</a>!
The FAVOR III trial (@favoriiitrial) 's Twitter Profile Photo

This morning, we reached a major milestone in the FAVOR III trial! Patient number 500 was enrolled by dr. Hernán Mejía-Renteria and his colleagues at Hospital Clinico San Carlos, Madrid. Beyond grateful for the collaboration! #QFR Niels R. Holm Evald Høj Christiansen Birgitte Krogsgaard HernánMR

This morning, we reached a major milestone in the FAVOR III trial! Patient number 500 was enrolled by dr. Hernán Mejía-Renteria and his colleagues at Hospital Clinico San Carlos, Madrid. Beyond grateful for the collaboration! #QFR <a href="/NielsRHolm/">Niels R. Holm</a> <a href="/h_evald/">Evald Høj Christiansen</a> <a href="/B_Krogsgaard/">Birgitte Krogsgaard</a> <a href="/HernanDMejiaR/">HernánMR</a>
The FAVOR III trial (@favoriiitrial) 's Twitter Profile Photo

Yesterday, prof. Gianluca Campo and his team in Ferrara enrolled patient no 1000 in the The FAVOR III trial. Ferrara is also the top enrolling center followed by Sahlgenska, Sweden and Clinique Axium, Aix-en-Provence, France. Simone Biscaglia Tebaldi Matteo Niels R. Holm

Yesterday, prof. <a href="/GianlucaCampo78/">Gianluca Campo</a> and his team in Ferrara enrolled patient no 1000 in the <a href="/FAVORIIITrial/">The FAVOR III trial</a>. Ferrara is also the top enrolling center followed by Sahlgenska, Sweden and Clinique Axium, Aix-en-Provence, France. <a href="/SimoneBiscaglia/">Simone Biscaglia</a> <a href="/Tebaldi_Matteo/">Tebaldi Matteo</a> <a href="/NielsRHolm/">Niels R. Holm</a>